1.45BMarket Cap-26625P/E (TTM)
34.910High34.880Low614.81KVolume34.900Open34.900Pre Close21.45MTurnover1.50%Turnover RatioLossP/E (Static)41.46MShares35.70052wk High4.78P/B1.43BFloat Cap18.50052wk Low--Dividend TTM41.08MShs Float178.980Historical High--Div YieldTTM0.09%Amplitude11.760Historical Low34.889Avg Price1Lot Size
Everbridge Stock Forum
UiPath (PATH) Potential Upside As ARR Should Beat Estimates
UiPath is expected to report a 24.4% increase in revenue to $383.826 million from $308.55 million a year ago, UiPath's guidance on 30 Jan 2023, for the period ended 31 Jan was for revenue between $381.00 million and $386.00 million.
Looking at UiPath's peers in the automation software...
NICE!
T1 News halt
ColumnsToday's Pre-Market Stock Movers And Top Ratings: JPM, ZG, TM, ZION and More
Gapping up
$Zillow-A(ZG.US)$ +5.5% (Zillow Group was upgraded by Piper Sandler to overweight from neutral. Analyst Thomas Champion also hiked his price target to $62 per share, suggesting 33% upside from Monday's close.)
$JPMorgan(JPM.US)$ +1.2% (JPMorgan Chase was upgraded from Jefferies to buy from hold. The firm also labeled JPMorgan Chase as“best-in-class.")
$3M(MMM.US)$ +2% (Shares rose n...
ColumnsToday's pre-market stock movers: RBLX, TTD, VLD, WYNN and more
In reaction to earnings/guidance:
• $The Trade Desk(TTD.US)$+17%,$Workiva(WK.US)$ +15.3%,$Arlo Technologies(ARLO.US)$ +12%,$Array Technologies(ARRY.US)$ +10.3%,$Everbridge(EVBG.US)$ +9.7%,$Catalyst Pharmaceuticals(CPRX.US)$ +9.4%,$Halozyme Therapeutics(HALO.US)$ +8.7%,$Velo3D(VLD.US)$ +7.6%,$CyberArk(CYBR.US)$ + 6.2%,$Haemonetics(HAE.US)$ +5.8%,$Jackson Financial(JXN.US)$ +5.7% (also increases dividend),$Axon Enterprise(AXON.US)$ +4.8%,...
No comment yet